CYPROTERONE\ETHINYL ESTRADIOL: 240 Adverse Event Reports & Safety Profile
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
240
Total FAERS Reports
1 (0.4%)
Deaths Reported
113
Hospitalizations
240
As Primary/Secondary Suspect
25
Life-Threatening
27
Disabilities
Active Ingredient: CYPROTERONE ACETATE\ETHINYL ESTRADIOL ·
First Report: 19860101 · Latest Report: 20250505
What Are the Most Common CYPROTERONE\ETHINYL ESTRADIOL Side Effects?
#1 Most Reported
Meningioma
63 reports (26.3%)
#2 Most Reported
Headache
41 reports (17.1%)
#3 Most Reported
Off label use
39 reports (16.3%)
All CYPROTERONE\ETHINYL ESTRADIOL Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Meningioma | 63 | 26.3% | 0 | 33 |
| Headache | 41 | 17.1% | 0 | 34 |
| Off label use | 39 | 16.3% | 0 | 27 |
| Asthenia | 30 | 12.5% | 0 | 27 |
| Fatigue | 30 | 12.5% | 0 | 28 |
| Pulmonary embolism | 29 | 12.1% | 1 | 22 |
| Visual impairment | 28 | 11.7% | 0 | 26 |
| Paraesthesia | 27 | 11.3% | 0 | 24 |
| Weight increased | 27 | 11.3% | 0 | 23 |
| Depression | 26 | 10.8% | 0 | 23 |
| Pain | 26 | 10.8% | 0 | 21 |
| Nausea | 25 | 10.4% | 0 | 16 |
| Gait disturbance | 24 | 10.0% | 0 | 21 |
| Malaise | 24 | 10.0% | 0 | 24 |
| Dizziness | 22 | 9.2% | 0 | 19 |
| Migraine | 22 | 9.2% | 0 | 18 |
| Neck pain | 22 | 9.2% | 0 | 22 |
| Product use in unapproved indication | 22 | 9.2% | 0 | 11 |
| Cognitive disorder | 21 | 8.8% | 0 | 21 |
| Diplopia | 21 | 8.8% | 0 | 18 |
Who Reports CYPROTERONE\ETHINYL ESTRADIOL Side Effects? Age & Gender Data
Gender: 94.8% female, 5.2% male. Average age: 35.2 years. Most reports from: FR. View detailed demographics →
Is CYPROTERONE\ETHINYL ESTRADIOL Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2000 | 4 | 0 | 4 |
| 2002 | 7 | 0 | 7 |
| 2004 | 2 | 0 | 1 |
| 2005 | 1 | 0 | 0 |
| 2006 | 3 | 1 | 3 |
| 2007 | 2 | 0 | 2 |
| 2008 | 1 | 0 | 0 |
| 2009 | 4 | 0 | 4 |
| 2010 | 2 | 0 | 1 |
| 2011 | 7 | 0 | 1 |
| 2012 | 4 | 0 | 1 |
| 2013 | 5 | 0 | 2 |
| 2014 | 4 | 0 | 1 |
| 2015 | 18 | 0 | 14 |
| 2016 | 14 | 0 | 5 |
| 2017 | 10 | 0 | 5 |
| 2018 | 13 | 0 | 7 |
| 2019 | 23 | 0 | 15 |
| 2020 | 12 | 0 | 3 |
| 2021 | 8 | 0 | 1 |
| 2022 | 7 | 0 | 0 |
| 2023 | 6 | 0 | 6 |
| 2024 | 6 | 0 | 2 |
| 2025 | 7 | 0 | 7 |
What Is CYPROTERONE\ETHINYL ESTRADIOL Used For?
| Indication | Reports |
|---|---|
| Contraception | 61 |
| Acne | 41 |
| Product used for unknown indication | 39 |
| Oral contraception | 23 |
| Polycystic ovaries | 14 |
| Haemorrhage | 12 |
| Migraine | 10 |
| Alopecia | 5 |
| Intentional overdose | 5 |
| Osteopenia | 5 |
CYPROTERONE\ETHINYL ESTRADIOL vs Alternatives: Which Is Safer?
CYPROTERONE\ETHINYL ESTRADIOL vs CYSTEAMINE
CYPROTERONE\ETHINYL ESTRADIOL vs CYTARABINE
CYPROTERONE\ETHINYL ESTRADIOL vs CYTARABINE\DAUNORUBICIN
CYPROTERONE\ETHINYL ESTRADIOL vs DABIGATRAN
CYPROTERONE\ETHINYL ESTRADIOL vs DABIGATRAN ETEXILATE
CYPROTERONE\ETHINYL ESTRADIOL vs DABRAFENIB
CYPROTERONE\ETHINYL ESTRADIOL vs DABRAFENIB\TRAMETINIB
CYPROTERONE\ETHINYL ESTRADIOL vs DACARBAZINE
CYPROTERONE\ETHINYL ESTRADIOL vs DACLATASVIR
CYPROTERONE\ETHINYL ESTRADIOL vs DACLIZUMAB
Official FDA Label for CYPROTERONE\ETHINYL ESTRADIOL
Official prescribing information from the FDA-approved drug label.